AP NEWS
Click to copy
Press release content from Business Wire. The AP news staff was not involved in its creation.
Click to copy
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

BioPharm International® Presents ‘From Small-Scale Stem Cell Production to Large-Scale hiPSC-Based Drug Development: The Flexibility of Stirred-Tank Bioreactors’ Webcast

September 11, 2019

CRANBURY, N.J.--(BUSINESS WIRE)--Sep 11, 2019--

BioPharm International®, a digital resource of technical articles, technology reports, regulatory and business columns, and expert commentary surrounding biopharmaceuticals, biotechnology and bioprocessing, will host a live webcast titled “From Small-Scale Stem Cell Production to Large-Scale hiPSC-Based Drug Development: The Flexibility of Stirred-Tank Bioreactors” on Monday, Sept. 16, at 9 a.m. EDT, 2 p.m. British Summer Time and 3 p.m. Central European Summer Time.

“Stirred-tank bioreactors are gaining more prevalence in the world of industrial production,” said Michael J. Hennessy Jr., president of MJH Life Sciences™, parent company of BioPharm International®. “In this live educational webcast, experts will explore stirred-tank bioreactors and the benefits of using them.”

The webcast includes the following speakers:

This webcast will discuss stirred-tank bioreactors and the importance in the industrial production of pharmaceutical products, biofuels and food. It will begin with a review of the basic principles of stirred-tank bioreactors and the factors that must be considered before and during the process. An expert discussion will follow and provide insight into how the advent of human-induced pluripotent stem cell (hiPSC) technology has substantially expanded the availability of human cells for drug discovery. Ncardia will also present a case study of large-scale manufacturing development and its hiPSC-based drug screening platform, DiscoverHIT.

To learn more and register, click here.

About BioPharm International®

BioPharm International® integrates the science and business of biopharmaceutical research, development and manufacturing. BioPharm International is a multimedia peer-reviewed resource on technical solutions to help biopharmaceutical professionals succeed in their work. This digital platform features peer-reviewed papers, technical articles, technology reports, regulatory and business columns, and expert commentary surrounding biopharmaceuticals, biotechnology, bioprocessing and all topics related to pharma manufacturing. BioPharm International® is a brand of MJH Life Sciences ™, the largest privately held, independent, full-service medical media company in the U.S.

View source version on businesswire.com:https://www.businesswire.com/news/home/20190911005551/en/

CONTACT: BioPharm International® MediaContact

John Patricolo, 609-325-4630

jpatricolo@mjhassoc.com

KEYWORD: NEW JERSEY UNITED STATES NORTH AMERICA

INDUSTRY KEYWORD: RESEARCH BIOTECHNOLOGY ALTERNATIVE MEDICINE PHARMACEUTICAL HEALTH OTHER SCIENCE SCIENCE

SOURCE: BioPharm International®

Copyright Business Wire 2019.

PUB: 09/11/2019 10:43 AM/DISC: 09/11/2019 10:43 AM

http://www.businesswire.com/news/home/20190911005551/en

All contents © copyright 2019 The Associated Press. All rights reserved.